PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects

Sophia N Verouti1, Elizabeth Fragopoulou, Haralabos C Karantonis

  • 1Faculty of Chemistry, National and Kapodistrian University of Athens, Panepistimioupolis, 15771 Athens, Greece.

Atherosclerosis
|September 17, 2011
PubMed
Abstract

Insights

Platelet-activating factor (PAF) and oxidized low-density lipoprotein (oxLDL) induce monocyte chemoattractant protein-1 (MCP-1) secretion and expression through oxidative stress pathways. These mediators, along with IL-1β, activate monocytes via G-proteins and NF-κB signaling.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Monocyte chemoattractant protein-1 (MCP-1) is crucial in inflammatory responses.
  • Platelet-activating factor (PAF), oxidized low-density lipoprotein (oxLDL), and IL-1β are implicated in monocyte activation and inflammation.
  • Understanding the differential effects and mechanisms of these mediators on monocyte function is essential.

Purpose of the Study:

  • To compare the effects of PAF, oxLDL, and IL-1β on MCP-1 and IL-6 secretion from U-937 monocytes.
  • To elucidate the underlying mechanisms of action, including signal transduction pathways and oxidative stress induction.

Main Methods:

  • U-937 monocytes were stimulated with PAF, oxLDL, or IL-1β.
  • MCP-1 and IL-6 secretion were quantified using ELISA.
  • mRNA levels of MCP-1 and PAF receptor (PAFR) were analyzed by real-time PCR.
  • Signal transduction pathways were investigated using specific inhibitors, and cellular oxidant status was assessed by measuring total thiols and glutathione levels.

Main Results:

  • None of the mediators induced IL-6 secretion.
  • PAF and oxLDL induced short-term MCP-1 secretion and expression, while IL-1β induced long-term effects.
  • Mediator-induced reduction in total thiol levels and GSH/GSSG ratio indicated oxidative stress.
  • Signal transduction involved G-proteins, protein kinases (PKC, serine-threonine, tyrosine), and NF-κB activation.
  • All mediators increased PAFR mRNA levels in activated monocytes.

Conclusions:

  • PAF, oxLDL, and IL-1β differentially regulate MCP-1 expression in monocytes.
  • These effects are mediated through pathways involving oxidative stress, G-protein signaling, and NF-κB activation.
  • PAF and oxLDL, distinct from IL-1β, modulate MCP-1 expression via redox-sensitive pathways.